161 related articles for article (PubMed ID: 10415894)
1. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver.
Remaury A; Ordener C; Shih J; Parini A
Ann N Y Acad Sci; 1999 Jun; 881():32-4. PubMed ID: 10415894
[TBL] [Abstract][Full Text] [Related]
2. Characterization of [3H]idazoxan binding proteins in solubilized membranes from rabbit and human liver.
Remaury A; Missy K; Parini A
J Auton Nerv Syst; 1998 Oct; 72(2-3):111-7. PubMed ID: 9851559
[TBL] [Abstract][Full Text] [Related]
3. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by I2 imidazoline ligands in intact cells.
Gargalidis-Moudanos C; Remaury A; Pizzinat N; Parini A
Mol Pharmacol; 1997 Apr; 51(4):637-43. PubMed ID: 9106629
[TBL] [Abstract][Full Text] [Related]
4. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
Alemany R; Olmos G; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models.
Remaury A; Raddatz R; Ordener C; Savic S; Shih JC; Chen K; Seif I; De Maeyer E; Lanier SM; Parini A
Mol Pharmacol; 2000 Nov; 58(5):1085-90. PubMed ID: 11040057
[TBL] [Abstract][Full Text] [Related]
6. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
Limon-Boulez I; Tesson F; Gargalidis-Moudanos C; Parini A
J Pharmacol Exp Ther; 1996 Feb; 276(2):359-64. PubMed ID: 8632297
[TBL] [Abstract][Full Text] [Related]
7. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
9. I2-imidazoline binding sites and monoamine oxidase activity in human postmortem brain from patients with Parkinson's disease.
Gargalidis-Moudanos C; Pizzinat N; Javoy-Agid F; Remaury A; Parini A
Neurochem Int; 1997 Jan; 30(1):31-6. PubMed ID: 9116585
[TBL] [Abstract][Full Text] [Related]
10. Localization of I2-imidazoline binding sites on monoamine oxidases.
Tesson F; Limon-Boulez I; Urban P; Puype M; Vandekerckhove J; Coupry I; Pompon D; Parini A
J Biol Chem; 1995 Apr; 270(17):9856-61. PubMed ID: 7730367
[TBL] [Abstract][Full Text] [Related]
11. Opposite age-dependent changes of alpha 2A-adrenoceptors and nonadrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) in the human brain: strong correlation of I2 with monoamine oxidase-B sites.
Sastre M; García-Sevilla JA
J Neurochem; 1993 Sep; 61(3):881-9. PubMed ID: 8395564
[TBL] [Abstract][Full Text] [Related]
12. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
[TBL] [Abstract][Full Text] [Related]
13. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
Raddatz R; Lanier SM
Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.
Soto J; Ulibarri I; Jauregui JV; Ballesteros J; Meana JJ
J Psychiatr Res; 1999; 33(3):251-7. PubMed ID: 10367991
[TBL] [Abstract][Full Text] [Related]
15. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
Renouard A; Widdowson PS; Cordi A
Br J Pharmacol; 1993 Jul; 109(3):625-31. PubMed ID: 8102932
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.
Escribá PV; Ozaita A; García-Sevilla JA
Ann N Y Acad Sci; 1999 Jun; 881():8-25. PubMed ID: 10415892
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
[TBL] [Abstract][Full Text] [Related]
18. Densities of I2-imidazoline receptors, alpha 2-adrenoceptors and monoamine oxidase B in brains of suicide victims.
Sastre M; García-Sevilla JA
Neurochem Int; 1997 Jan; 30(1):63-72. PubMed ID: 9116589
[TBL] [Abstract][Full Text] [Related]
19. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.
Lanier B; Raddatz R; Bakthavachalam V; Coupry I; Neumeyer JL; Lanier SM
Mol Pharmacol; 1995 Oct; 48(4):703-10. PubMed ID: 7476897
[TBL] [Abstract][Full Text] [Related]
20. Binding of [3H]2-(2-benzofuranyl)-2-imidazoline (BFI) to human brain: potentiation by tranylcypromine.
Wiest SA; Steinberg MI
Life Sci; 1997; 60(9):605-15. PubMed ID: 9048963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]